Ikarian Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-89,219
| Closed | -$10.2M | – | 106 |
|
|
2022
Q4 | $10.2M | Buy |
89,219
+15,000
| +20% | +$1.71M | 2.45% | 7 |
|
|
2022
Q3 | $4.59M | Sell |
74,219
-85,897
| -54% | -$5.32M | 0.92% | 18 |
|
|
2022
Q2 | $12.8M | Buy |
160,116
+50,000
| +45% | +$3.99M | 2.33% | 3 |
|
|
2022
Q1 | $11.6M | Buy |
110,116
+34,455
| +46% | +$3.62M | 1.52% | 5 |
|
|
2021
Q4 | $8.15M | Buy |
75,661
+50,000
| +195% | +$5.39M | 1.21% | 10 |
|
|
2021
Q3 | $2.81M | Sell |
25,661
-29,154
| -53% | -$3.19M | 0.2% | 57 |
|
|
2021
Q2 | $5.13M | Buy |
54,815
+54,212
| +8,990% | +$5.08M | 0.42% | 31 |
|
|
2021
Q1 | $56K | Buy |
+603
| New | +$56K | ﹤0.01% | 173 |
|
|
2020
Q4 | – | Sell |
-2,641
| Closed | -$205K | – | 208 |
|
|
2020
Q3 | $205K | Buy |
+2,641
| New | +$205K | 0.01% | 92 |
|